Inventor
FRYE STEPHEN
US17 patents
⚠️ This page may combine multiple inventors who share the name “FRYE STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV NORTH CAROLINA CHAPEL HILL
11 patentsUS10004755B2Jun 26, 2018
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL8 citations84
US9555031B2Jan 31, 2017
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL4 citations84
US9555030B2Jan 31, 2017
Therapeutic uses of selected pyrazolopyrimidine compounds with anti-Mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL3 citations84
US9649309B2May 16, 2017
Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL2 citations73
US9603850B2Mar 28, 2017
MerTK-specific pyrazolopyrimidine compounds
UNIV NORTH CAROLINA CHAPEL HILL3 citations73
US9795606B2Oct 24, 2017
Pyrrolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL2 citations72
US9562047B2Feb 7, 2017
Pyrazolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL3 citations72
US11339178B2May 24, 2022
Inhibitors of microbial beta-glucuronidase enzymes and uses thereof
UNIV NORTH CAROLINA CHAPEL HILL0 citations52
US10179133B2Jan 15, 2019
Pyrrolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL0 citations51
US9744172B2Aug 29, 2017
Pyrazolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL0 citations51
US12448365B2Oct 21, 2025
Aryl aminopyrimidines as dual MerTK and TYRO3 inhibitors and methods thereof
UNIV NORTH CAROLINA CHAPEL HILL0 citations41